Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-28

Clinical Trial Update: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as Maintenance Treatment in Patients With Chronic Renal Anemia on Haemodialysis

View source ↗

Summary

An observational study evaluating Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as maintenance therapy for chronic renal anemia in patients on haemodialysi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia, Kidney Disease, Chronic | Status: COMPLETED | Results posted: 2016-03-28